Publication:
The development of extraintestinal manifestation and related risk factors in Crohn’s patients

dc.contributor.coauthorKayar, Yusuf
dc.contributor.coauthorDertli, Ramazan
dc.contributor.coauthorKonur, Şevki
dc.contributor.coauthorAğın, Mehmet
dc.contributor.coauthorÖrmeci, Aslı Çiftçibaşı
dc.contributor.coauthorAkyüz, Filiz
dc.contributor.coauthorDemir, Kadir
dc.contributor.coauthorBeşışık, Fatih
dc.contributor.coauthorKaymakoğlu, Sabahattin
dc.contributor.kuauthorBaran, Bülent
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokidN/A
dc.date.accessioned2024-11-09T23:22:38Z
dc.date.issued2021
dc.description.abstractBackground Crohn's disease (CD) primarily involves gastrointestinal tract; however, it can present with extraintestinal manifestations (EIMs), which leads to significant morbidity. Frequency of EIMs and associated risk factors vary due to genetic and environmental differences in studies. Aim To examine the frequency and risk factors associated with EIMs in CD. Method Patients with CD under follow-up from March 1986 to October 2011 were included in this study. Demographics, type of EIMs, autoimmune diseases, and clinical features of CD were recorded. Frequency of EIMs and associated risk factors were analyzed. Results Three hundred thirty-six patients with CD were included in the study (mean follow-up duration 7.54 years). 55.4% (n: 186) were male and the mean age at diagnosis of CD was 30.6 years (range, 10.3-68.2 years). At least one EIM was detected in 47.3% and multiple EIMs in 22.9% of the cohort. Oral, joint, and skin involvements (32.4%, 24.7%, 9.2%, respectively) were the most common EIMs. Female gender (OR: 2.19, 95% CI: 1.34-3.58,p = 0.001), corticosteroid usage (OR: 2.32, 95% CI: 1.28-4.22,p = 0.007), and positive family history (OR: 5.61, 95% CI: 1.95-3.58,p = 0.001) were independent risk factors for EIM development. Colonic involvement (OR: 3.93, 95% CI: 1.59-9.68,p = 0.003), no surgical operation (OR: 2.31, 95% CI: 1.14-4.68,p = 0.020), and corticosteroid usage (OR: 2.85, 95% CI: 1.07-7.61,p = 0.037) were independent risk factors for multiple EIM development. Conclusion Although the immunological and clinical associations between EIMs and CD cannot be fully elucidated, identifying specific relationships of immune-mediated diseases will help to better understand CD pathogenesis.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume190
dc.identifier.doi10.1007/s11845-020-02326-z
dc.identifier.eissn1863-4362
dc.identifier.issn0021-1265
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85088942975
dc.identifier.urihttp://dx.doi.org/10.1007/s11845-020-02326-z
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11102
dc.identifier.wos555356000001
dc.keywordsAssociated factors
dc.keywordsCrohn disease
dc.keywordsExtraintestinal manifestations Inflammatory-Bowel-Disease
dc.keywordsUlcerative-Colitis
dc.keywordsAfrican-Americans
dc.keywordsFollow-Up
dc.keywordsClassification
dc.keywordsComplications
dc.keywordsAssociation
dc.keywordsPrevalence
dc.keywordsHispanics Phenotype
dc.languageEnglish
dc.publisherSpringer London Ltd
dc.sourceIrish Journal of Medical Science
dc.subjectMedicine, General Internal
dc.titleThe development of extraintestinal manifestation and related risk factors in Crohn’s patients
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0001-7966-2346
local.contributor.kuauthorBaran, Bülent

Files